Panelists discuss how advanced basal cell carcinoma (BCC) management requires a nuanced approach, emphasizing the importance of early detection, multidisciplinary collaboration, personalized treatment strategies, and ongoing patient monitoring to optimize outcomes and quality of life.
Panelists discuss how the role of AI in Hidradenitis Suppurativa and the potential for complex multi-input factors.
Getting denied for injection administration can be common. How to make sure you get paid.
Explore solutions for facial volume loss, skin laxity, and in some cases—skin excess.
Anthony M. Rossi, MD, shares their perspective on the future evolution of photodynamic therapy (PDT) in dermatology practices and discusses emerging data or studies that will be crucial for dermatologists to stay informed about.
Adamson dives deep into artificial intelligence, molecular testing, and melanoma overdiagnosis.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Panelists discuss how emerging nonsurgical options such as hedgehog pathway inhibitors, immune checkpoint inhibitors, and photodynamic therapy are expanding treatment possibilities for patients with advanced basal cell carcinoma (BCC), particularly for those unsuitable for or unresponsive to traditional surgical interventions.
Explore 2025’s dermatology M&A trends, economic shifts, and key investment drivers shaping the industry's future.
It is important dermatologists learn to recognize the clinical findings of dermatophytomas and distinguish them from other onychomycosis subtypes because the recommended treatments differ.
The COVID-19 pandemic reshaped dermatology through telehealth, social media, and increased cosmetic procedures. Challenges and opportunities persist as practices adapt.
Jorge Garcia-Zuazaga, MD, MBA, FAAD, FACMS, discusses Apex Dermatology's Purple Heart Project.
In recent years, there has been a noticeable rise in diagnoses of sexually transmitted infections, often which present with skin findings.
The 3rd Annual San Diego Dermatology Symposium (SDDS) was held in-person for the first time on March 11 to 13, 2022, at the Hilton San Diego Bayfront, in California.
Michael Sherling, MD, MBA, leverages AI to simplify administrative tasks and focus on patient care.
At RAD 2025, Tiffany Mayo, MD, emphasized the need for clinicians to recognize shared inflammatory mechanisms between AD and AA.
For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.
COVID-19 is prompting significant changes to malpractice laws and regulations at the state and federal levels.
This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.
Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.
With hormonal fluctuations, constantly changing schedules, and various afterschool activities, addressing the specific needs of teenage skin becomes essential to promote a lifetime of proper skin care practices.
Smidt and Hunt offer insights on navigating pediatric dermatology decision-making, emphasizing learning from clinical scenarios and fostering a culture of feedback and improvement.